AUS
NZ
UK
CA
USA
IND
Magontec Limited (ASX:MGL), a magnesium technology and recycling company listed on the ASX, has issued 1,055,884 unquoted performance rights to its employees and key management personnel under its Long-Term Incentive Plan, effective 1 July 2026. A substantial portion of these rights, amounting to 675,918, were allocated to Christoph Klein-Schmeink, a key management personnel member, highlighting the company's focus on aligning executive rewards with long-term shareholder interests. These performance rights, designated under the security code MGLAA, are not intended for ASX quotation. Following this issuance, the total number of unquoted performance rights outstanding now reaches 9,759,809, a key figure for investors monitoring Magontec's equity and incentive framework.<\/p> <\/div>
Key Points<\/h3>
- Issuer: Magontec Limited (ASX:MGL)<\/li>
- 1,055,884 performance rights (MGLAA) issued on 1 July 2026 under the Long-Term Incentive Plan<\/li>
- 675,918 performance rights granted to KMP member Christoph Klein-Schmeink<\/li>
- Total unquoted performance rights outstanding now 9,759,809; quoted ordinary shares remain at 57,934,806<\/li>
- Issuance approved under ASX Listing Rule 7.2 Exception 13, requiring no shareholder approval<\/li>
- Investors should monitor disclosures on vesting criteria and potential conversion of rights into shares<\/li>
<\/ul>
<\/div>
Details of Magontec’s 1 July 2026 Performance Rights Issuance<\/h2>
On 1 July 2026, Magontec Limited formally announced the issuance of 1,055,884 unquoted performance rights under the code MGLAA. These rights do not trade on the ASX like the company’s ordinary shares (MGL). The announcement was made via an Appendix 3G filing, the standard disclosure form for unquoted equity securities.<\/p>
The newly issued performance rights rank equally with existing securities in the MGLAA class from their issue date, a typical feature of employee incentive instruments. The company’s update did not specify the vesting conditions or performance hurdles for this tranche, but full terms are available in the Long-Term Incentive Plan document approved at the May 2024 Annual General Meeting.<\/p>
Allocation to Christoph Klein-Schmeink as Key Management Personnel<\/h2>
Out of the total performance rights issued, 675,918 were allocated to Christoph Klein-Schmeink, a member of Magontec’s key management personnel, with the rights registered in his name. This allocation accounts for about 64% of the tranche, reflecting a significant incentive weighting toward senior management.<\/p>
The company confirmed that the issuance to key management personnel triggers disclosure obligations under ASX Listing Rules and the Corporations Act. The remaining 379,966 rights were granted to other eligible participants, whose identities were not disclosed, consistent with standard practice.<\/p>
Governance of the Grant Under the Long-Term Incentive Plan<\/h2>
The performance rights were issued pursuant to Magontec’s Long-Term Incentive Plan, approved by shareholders at the 15 May 2024 AGM. The plan’s full terms, including eligibility, vesting conditions, and other rules, are publicly accessible on the company’s website as referenced in the announcement.<\/p>
Such plans aim to link remuneration to long-term business performance rather than short-term results. Performance rights typically convert into ordinary shares once specified vesting conditions—such as financial targets, share price milestones, or continued employment—are met. Specific vesting criteria for this tranche were not detailed in the announcement; investors should consult the plan documentation for comprehensive information.<\/p>
Issuance Approved Under Listing Rule 7.2 Exception 13<\/h2>
The issuance was conducted under Exception 13 of ASX Listing Rule 7.2, meaning it did not require shareholder approval under Listing Rule 7.1. Normally, Listing Rule 7.1 limits equity issues without shareholder consent to 15% of issued capital within 12 months. Exception 13 applies to securities issued under an employee incentive scheme previously approved by shareholders, in this case, the Long-Term Incentive Plan approved in May 2024.<\/p>
This approach is commonly used by ASX-listed companies to facilitate employee incentive grants without the need for individual shareholder votes. Although no meeting was required for this grant, Magontec remains obligated to disclose such issuances through formal filings like Appendix 3G.<\/p>
Total Unquoted Performance Rights Pool Now at 9,759,809<\/h2>
Following this issuance, the total unquoted performance rights outstanding under the MGLAA class reached 9,759,809. This total includes all previously granted performance rights that have not yet converted or lapsed combined with the new 1,055,884 rights. The company noted that figures may not fully reflect the current issued capital if other filings are being processed concurrently by the ASX.<\/p>
For reference, the total number of quoted ordinary fully paid shares (MGL) remains at 57,934,806. The performance rights pool represents a potential dilution of approximately 16.8% of the current ordinary shares if all rights vest and convert. However, conversion depends on meeting vesting conditions, and some rights may lapse. The actual dilution will depend on future vesting outcomes, which were not forecast in this announcement.<\/p>
Implications of the MGLAA Performance Rights Pool Size for Magontec’s Incentive Strategy<\/h2>
The issuance of over one million performance rights in this tranche, adding to an existing pool of nearly 8.7 million rights, indicates Magontec’s active long-term incentive program since the plan’s approval in May 2024. This scale relative to the ordinary share base suggests the board prioritizes equity-based remuneration to retain and motivate key personnel.<\/p>
For shareholders, such equity incentives offer alignment of management and employee interests with those of shareholders, especially when tied to performance hurdles. Conversely, the accumulation of performance rights means future vesting will issue new shares, diluting existing holders incrementally. Investors should monitor the company’s Annual Report and remuneration disclosures for detailed vesting terms and timelines.<\/p>
Ordinary Share Count Remains Unchanged at 57,934,806<\/h2>
The company confirmed that the number of quoted ordinary fully paid shares (MGL) remains stable at 57,934,806 following this transaction. Performance rights represent conditional future share entitlements and only increase the ordinary share count upon vesting and conversion.<\/p>
This distinction is important for investors evaluating Magontec’s capitalisation. The market capitalisation of MGL shares is unaffected immediately by this grant. The share price impact was not apparent from public information, as such grants under pre-approved schemes are typically routine corporate matters.<\/p>
Company Background and Role of Equity Incentives<\/h2>
Magontec Limited operates in magnesium technology, including recycling and alloy production, with a global footprint. Retaining skilled management and technical staff internationally is a significant board priority, and equity-based incentives are a common strategy for companies of similar scale.<\/p>
The Long-Term Incentive Plan, approved by shareholders in May 2024, provides the framework for issuing performance rights and other equity securities to eligible participants. The plan was approved transparently and in line with ASX governance standards. Grants such as the 1 July 2026 tranche occur within this approved framework and are disclosed promptly through regulatory filings.<\/p>
Investor Considerations and Future Monitoring<\/h2>
Investors and analysts tracking Magontec’s equity and incentive arrangements should watch for further disclosures on the vesting conditions specific to the 1 July 2026 tranche, including any financial or share price performance hurdles. While the general plan terms are public, tranche-specific details are often found in the company’s annual remuneration report.<\/p>
Additionally, investors should monitor for future performance rights issuances under the plan and notifications of vesting events converting MGLAA rights into ordinary MGL shares. Annual general meeting materials and remuneration reports will be crucial for assessing the company’s outstanding incentive obligations and progress against performance targets. No forward guidance on vesting timing was provided in this update.<\/p>
Details of Magontec’s 1 July 2026 Performance Rights Issuance<\/h2>
On 1 July 2026, Magontec Limited formally announced the issuance of 1,055,884 unquoted performance rights under the code MGLAA. These rights do not trade on the ASX like the company’s ordinary shares (MGL). The announcement was made via an Appendix 3G filing, the standard disclosure form for unquoted equity securities.<\/p>
The newly issued performance rights rank equally with existing securities in the MGLAA class from their issue date, a typical feature of employee incentive instruments. The company’s update did not specify the vesting conditions or performance hurdles for this tranche, but full terms are available in the Long-Term Incentive Plan document approved at the May 2024 Annual General Meeting.<\/p>
Allocation to Christoph Klein-Schmeink as Key Management Personnel<\/h2>
Out of the total performance rights issued, 675,918 were allocated to Christoph Klein-Schmeink, a member of Magontec’s key management personnel, with the rights registered in his name. This allocation accounts for about 64% of the tranche, reflecting a significant incentive weighting toward senior management.<\/p>
The company confirmed that the issuance to key management personnel triggers disclosure obligations under ASX Listing Rules and the Corporations Act. The remaining 379,966 rights were granted to other eligible participants, whose identities were not disclosed, consistent with standard practice.<\/p>
Governance of the Grant Under the Long-Term Incentive Plan<\/h2>
The performance rights were issued pursuant to Magontec’s Long-Term Incentive Plan, approved by shareholders at the 15 May 2024 AGM. The plan’s full terms, including eligibility, vesting conditions, and other rules, are publicly accessible on the company’s website as referenced in the announcement.<\/p>
Such plans aim to link remuneration to long-term business performance rather than short-term results. Performance rights typically convert into ordinary shares once specified vesting conditions—such as financial targets, share price milestones, or continued employment—are met. Specific vesting criteria for this tranche were not detailed in the announcement; investors should consult the plan documentation for comprehensive information.<\/p>
Issuance Approved Under Listing Rule 7.2 Exception 13<\/h2>
The issuance was conducted under Exception 13 of ASX Listing Rule 7.2, meaning it did not require shareholder approval under Listing Rule 7.1. Normally, Listing Rule 7.1 limits equity issues without shareholder consent to 15% of issued capital within 12 months. Exception 13 applies to securities issued under an employee incentive scheme previously approved by shareholders, in this case, the Long-Term Incentive Plan approved in May 2024.<\/p>
This approach is commonly used by ASX-listed companies to facilitate employee incentive grants without the need for individual shareholder votes. Although no meeting was required for this grant, Magontec remains obligated to disclose such issuances through formal filings like Appendix 3G.<\/p>
Total Unquoted Performance Rights Pool Now at 9,759,809<\/h2>
Following this issuance, the total unquoted performance rights outstanding under the MGLAA class reached 9,759,809. This total includes all previously granted performance rights that have not yet converted or lapsed combined with the new 1,055,884 rights. The company noted that figures may not fully reflect the current issued capital if other filings are being processed concurrently by the ASX.<\/p>
For reference, the total number of quoted ordinary fully paid shares (MGL) remains at 57,934,806. The performance rights pool represents a potential dilution of approximately 16.8% of the current ordinary shares if all rights vest and convert. However, conversion depends on meeting vesting conditions, and some rights may lapse. The actual dilution will depend on future vesting outcomes, which were not forecast in this announcement.<\/p>
Implications of the MGLAA Performance Rights Pool Size for Magontec’s Incentive Strategy<\/h2>
The issuance of over one million performance rights in this tranche, adding to an existing pool of nearly 8.7 million rights, indicates Magontec’s active long-term incentive program since the plan’s approval in May 2024. This scale relative to the ordinary share base suggests the board prioritizes equity-based remuneration to retain and motivate key personnel.<\/p>
For shareholders, such equity incentives offer alignment of management and employee interests with those of shareholders, especially when tied to performance hurdles. Conversely, the accumulation of performance rights means future vesting will issue new shares, diluting existing holders incrementally. Investors should monitor the company’s Annual Report and remuneration disclosures for detailed vesting terms and timelines.<\/p>
Ordinary Share Count Remains Unchanged at 57,934,806<\/h2>
The company confirmed that the number of quoted ordinary fully paid shares (MGL) remains stable at 57,934,806 following this transaction. Performance rights represent conditional future share entitlements and only increase the ordinary share count upon vesting and conversion.<\/p>
This distinction is important for investors evaluating Magontec’s capitalisation. The market capitalisation of MGL shares is unaffected immediately by this grant. The share price impact was not apparent from public information, as such grants under pre-approved schemes are typically routine corporate matters.<\/p>
Company Background and Role of Equity Incentives<\/h2>
Magontec Limited operates in magnesium technology, including recycling and alloy production, with a global footprint. Retaining skilled management and technical staff internationally is a significant board priority, and equity-based incentives are a common strategy for companies of similar scale.<\/p>
The Long-Term Incentive Plan, approved by shareholders in May 2024, provides the framework for issuing performance rights and other equity securities to eligible participants. The plan was approved transparently and in line with ASX governance standards. Grants such as the 1 July 2026 tranche occur within this approved framework and are disclosed promptly through regulatory filings.<\/p>
Investor Considerations and Future Monitoring<\/h2>
Investors and analysts tracking Magontec’s equity and incentive arrangements should watch for further disclosures on the vesting conditions specific to the 1 July 2026 tranche, including any financial or share price performance hurdles. While the general plan terms are public, tranche-specific details are often found in the company’s annual remuneration report.<\/p>
Additionally, investors should monitor for future performance rights issuances under the plan and notifications of vesting events converting MGLAA rights into ordinary MGL shares. Annual general meeting materials and remuneration reports will be crucial for assessing the company’s outstanding incentive obligations and progress against performance targets. No forward guidance on vesting timing was provided in this update.<\/p>
